Insmed Inc. buy Cantor Fitzgerald
Start price
19.02.25
/
50%
€78.00
Target price
19.02.26
-
Performance (%)
74.36%
End price
20.02.26
€136.00
Summary
This prediction ended on 20.02.26 with a price of €136.00. With a performance of 74.36% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -12.096% | -12.096% | -6.083% |
| iShares Core DAX® | -1.337% | 1.399% | 2.620% |
| iShares Nasdaq 100 | -2.990% | 2.183% | 33.890% |
| iShares Nikkei 225® | -2.903% | 4.319% | 52.995% |
| iShares S&P 500 | -2.324% | 1.484% | 22.860% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten